Literature DB >> 33259204

How do Self-Assembling Antimicrobial Lipopeptides Kill Bacteria?

Haoning Gong1,2, Marc-Antoine Sani3, Xuzhi Hu1, Ke Fa1, Jack William Hart1,4, Mingrui Liao1,2, Peter Hollowell1, Jessica Carter1, Luke A Clifton5, Mario Campana5, Peixun Li5, Stephen M King5, John R P Webster5, Armando Maestro6, Shiying Zhu3, Frances Separovic3, Thomas A Waigh1,4, Hai Xu7, Andrew J McBain2, Jian Ren Lu1.   

Abstract

Antimicrobial peptides are promising alternatives to traditional antibiotics. A group of self-assembling lipopeptides was formed by attaching an acyl chain to the N-terminus of α-helix-forming peptides with the sequence Cx-G(IIKK)yI-NH2 (CxGy, x = 4-12 and y = 2). CxGy self-assemble into nanofibers above their critical aggregation concentrations (CACs). With increasing x, the CACs decrease and the hydrophobic interactions increase, promoting secondary structure transitions within the nanofibers. Antimicrobial activity, determined by the minimum inhibition concentration (MIC), also decreases with increasing x, but the MICs are significantly smaller than the CACs, suggesting effective bacterial membrane-disrupting power. Unlike conventional antibiotics, both C8G2 and C12G2 can kill Staphylococcus aureus and Escherichia coli after only minutes of exposure under the concentrations studied. C12G2 nanofibers have considerably faster killing dynamics and lower cytotoxicity than their nonaggregated monomers. Antimicrobial activity of peptide aggregates has, to date, been underexploited, and it is found to be a very promising mechanism for peptide design. Detailed evidence for the molecular mechanisms involved is provided, based on superresolution fluorescence microscopy, solid-state nuclear magnetic resonance, atomic force microscopy, neutron scattering/reflectivity, circular dichroism, and Brewster angle microscopy.

Entities:  

Keywords:  antimicrobial peptides; bionanomaterials; infection control; membrane disruption; membrane-lytic; nanofibrils; self-assembly; wound care

Year:  2020        PMID: 33259204     DOI: 10.1021/acsami.0c17222

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  5 in total

1.  Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens.

Authors:  Josefine Eilsø Nielsen; Morgan Ashley Alford; Deborah Bow Yue Yung; Natalia Molchanova; John A Fortkort; Jennifer S Lin; Gill Diamond; Robert E W Hancock; Håvard Jenssen; Daniel Pletzer; Reidar Lund; Annelise E Barron
Journal:  ACS Infect Dis       Date:  2022-02-17       Impact factor: 5.084

2.  Emergent antibacterial activity of N-(thiazol-2-yl)benzenesulfonamides in conjunction with cell-penetrating octaarginine.

Authors:  Poonam Ratrey; Amarjyoti Das Mahapatra; Shiny Pandit; Murtuza Hadianawala; Sasmita Majhi; Abhijit Mishra; Bhaskar Datta
Journal:  RSC Adv       Date:  2021-08-25       Impact factor: 4.036

3.  In-Membrane Nanostructuring of Cationic Amphiphiles Affects Their Antimicrobial Efficacy and Cytotoxicity: A Comparison Study between a De Novo Antimicrobial Lipopeptide and Traditional Biocides.

Authors:  Ke Fa; Huayang Liu; Haoning Gong; Lin Zhang; Mingrui Liao; Xuzhi Hu; Daniela Ciumac; Peixun Li; John Webster; Jordan Petkov; Robert K Thomas; Jian Ren Lu
Journal:  Langmuir       Date:  2022-05-19       Impact factor: 4.331

Review 4.  A technical review of face mask wearing in preventing respiratory COVID-19 transmission.

Authors:  Mingrui Liao; Huayang Liu; Xi Wang; Xuzhi Hu; Yuhao Huang; Xuqing Liu; Keith Brenan; Jared Mecha; Mahesan Nirmalan; Jian Ren Lu
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-01-29       Impact factor: 6.448

5.  Design and Characterization of Myristoylated and Non-Myristoylated Peptides Effective against Candida spp. Clinical Isolates.

Authors:  Francesca Bugli; Federica Massaro; Francesco Buonocore; Paolo Roberto Saraceni; Stefano Borocci; Francesca Ceccacci; Cecilia Bombelli; Maura Di Vito; Rosalba Marchitiello; Melinda Mariotti; Riccardo Torelli; Maurizio Sanguinetti; Fernando Porcelli
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.